Related references
Note: Only part of the references are listed.Strategies for fighting pandemic virus infections: Integration of virology and drug delivery
Takashi Nakamura et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Intravenous liposomal vaccine enhances CTL generation, but not until antigen presentation
Takashi Nakamura et al.
JOURNAL OF CONTROLLED RELEASE (2022)
The hydrophobic tail of a pH-sensitive cationic lipid influences siRNA transfection activity and toxicity in human NK cell lines
Takashi Nakamura et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
The Next Decade of Immune Checkpoint Therapy
Padmanee Sharma et al.
CANCER DISCOVERY (2021)
Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop
Francesco Marangoni et al.
CELL (2021)
Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment
Ellen N. Scott et al.
FRONTIERS IN IMMUNOLOGY (2021)
STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation
Takashi Nakamura et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
STING Agonists as Cancer Therapeutics
Afsaneh Amouzegar et al.
CANCERS (2021)
Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling
Kim Bich Nguyen et al.
JOURNAL OF CELL BIOLOGY (2020)
Distribution of BCG-CWS-Loaded Nanoparticles in the Spleen After Intravenous Injection Affects Cytotoxic T Lymphocyte Activity
Hideyuki Masuda et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Vitamin E Scaffolds of pH-Responsive Lipid Nanoparticles as DNA Vaccines in Cancer and Protozoan Infection
Mio Maeta et al.
MOLECULAR PHARMACEUTICS (2020)
The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer
John Kwon et al.
CANCER DISCOVERY (2020)
Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model
Barbara Schroers et al.
FRONTIERS IN ONCOLOGY (2020)
A novel scoring method based on RNA-Seq immunograms describing individual cancer-immunity interactions
Yukari Kobayashi et al.
CANCER SCIENCE (2020)
Lipid nanoparticles fuse with cell membranes of immune cells at low temperatures leading to the loss of transfection activity
Takashi Nakamura et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Integrative immunogenomic analysis of gastric cancer dictates novel immunological classification and the functional status of tumor-infiltrating cells
Yasuyoshi Sato et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni et al.
NATURE REVIEWS CANCER (2020)
Enhancing cancer immunotherapy with nanomedicine
Darrell J. Irvine et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Collagen density regulates the activity of tumor-infiltrating T cells
Dorota E. Kuczek et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Combining Nanomedicine and Immunotherapy
Yang Shi et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy
Rikito Endo et al.
SCIENTIFIC REPORTS (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events
Yoshiyuki Nakamura
FRONTIERS IN MEDICINE (2019)
Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
Shetal A. Patel et al.
IMMUNITY (2018)
Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core
Takashi Nakamura et al.
MOLECULAR PHARMACEUTICS (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
DNA-loaded nano-adjuvant formed with a vitamin E-scaffold intracellular environmentally-responsive lipid-like material for cancer immunotherapy
Minori Kawai et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology
Hideyuki Masuda et al.
MOLECULAR PHARMACEUTICS (2018)
A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer
Ning Cheng et al.
JCI INSIGHT (2018)
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
Vikram R. Juneja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
An Immunogram Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer
Takahiro Karasaki et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Integration of nano drug-delivery system with cancer immunotherapy
Takashi Nakamura et al.
THERAPEUTIC DELIVERY (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Emerging Opportunities and Challenges in Cancer Immunotherapy
Theresa L. Whiteside et al.
CLINICAL CANCER RESEARCH (2016)
A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells
Shota Warashina et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
Olivier De Henau et al.
NATURE (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
The cancer immunogram
Christian U. Blank et al.
SCIENCE (2016)
Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
Takashi Nakamura et al.
SCIENTIFIC REPORTS (2016)
Innate Immune Pattern Recognition: A Cell Biological Perspective
Sky W. Brubaker et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
Sonja Kleffel et al.
CELL (2015)
Nanoparticu late STING agonists are potent lymph node-targeted vaccine adjuvants
Melissa C. Hanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma
Takashi Nakamura et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Nanoparticulation of BCG-CWS for application to bladder cancer therapy
Takashi Nakamura et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Mechanism responsible for the antitumor effect of BCG-CWS using the LEEL method in a mouse bladder cancer model
Takashi Nakamura et al.
JOURNAL OF CONTROLLED RELEASE (2014)
A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy
Hiroko Miyabe et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Octaarginine-Modified Liposomes Enhance Cross-Presentation by Promoting the C-Terminal Trimming of Antigen Peptide
Takashi Nakamura et al.
MOLECULAR PHARMACEUTICS (2014)
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Gregory T. Motz et al.
NATURE MEDICINE (2014)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Incorporation of polyinosine-polycytidylic acid enhances cytotoxic T cell activity and antitumor effects by octaarginine-modified liposomes encapsulating antigen, but not by octaarginine-modified antigen complex
Takashi Nakamura et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration
Takashi Nakamura et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
Tyler R. Simpson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene et al.
NATURE (2011)
Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation
Sachiko Hirosue et al.
VACCINE (2010)
Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes
Takashi Nakamura et al.
MOLECULAR THERAPY (2008)
Share Paper
